- Home
- WATT vs HCWB Comparison
WATT vs HCWB Comparison
Compare WATT & HCWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WATT
- HCWB
- Stock Information
- Founded
- WATT 2012
- HCWB 2018
- Country
- WATT United States
- HCWB United States
- Employees
- WATT N/A
- HCWB N/A
- Industry
- WATT Radio And Television Broadcasting And Communications Equipment
- HCWB Biotechnology: Pharmaceutical Preparations
- Sector
- WATT Technology
- HCWB Health Care
- Exchange
- WATT Nasdaq
- HCWB Nasdaq
- Market Cap
- WATT 9.3M
- HCWB 10.8M
- IPO Year
- WATT 2014
- HCWB 2021
- Fundamental
- Price
- WATT $0.29
- HCWB $4.48
- Analyst Decision
- WATT
- HCWB Strong Buy
- Analyst Count
- WATT 0
- HCWB 1
- Target Price
- WATT N/A
- HCWB $35.00
- AVG Volume (30 Days)
- WATT 2.5M
- HCWB 112.9K
- Earning Date
- WATT 07-29-2025
- HCWB 08-13-2025
- Dividend Yield
- WATT N/A
- HCWB N/A
- EPS Growth
- WATT N/A
- HCWB N/A
- EPS
- WATT N/A
- HCWB N/A
- Revenue
- WATT $1,976,000.00
- HCWB $1,445,145.00
- Revenue This Year
- WATT $1,028.91
- HCWB $178.36
- Revenue Next Year
- WATT N/A
- HCWB N/A
- P/E Ratio
- WATT N/A
- HCWB N/A
- Revenue Growth
- WATT 434.05
- HCWB N/A
- 52 Week Low
- WATT $0.12
- HCWB $3.55
- 52 Week High
- WATT $2.70
- HCWB $100.80
- Technical
- Relative Strength Index (RSI)
- WATT 37.22
- HCWB 48.65
- Support Level
- WATT $0.35
- HCWB $4.02
- Resistance Level
- WATT $0.61
- HCWB $4.61
- Average True Range (ATR)
- WATT 0.07
- HCWB 0.32
- MACD
- WATT -0.02
- HCWB 0.08
- Stochastic Oscillator
- WATT 0.09
- HCWB 52.33
About WATT Energous Corporation
Energous Corp has developed wireless power networks technology (WPNT), consisting of semiconductor chipsets, software controls, hardware designs, and antennas, that enable radio frequency (RF) based charging for Internet of Things (IoT) devices. The WPN technology provides a comprehensive suite of capabilities designed to power the next generation of wireless energy networks, seamlessly delivering power and data across diverse, battery-free device ecosystems. It enhances operational visibility, control, and intelligent business automation. Its products include Transmitter IC & Module, Receivers IC, Transmitter System, and Evaluation Kits.
About HCWB HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.